Controlling Schistosomiasis in Southeast Asia. A Tale of Two Countries

Advances in Parasitology

Volumn 72, Issue C, 2010, Pages 109-144

  Bergquist, Robert ^a   Tanner, Marcel ^b,c  

^a Brastad   (Sweden)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ARTEMETHER; ARTESUNATE; GLUTATHIONE TRANSFERASE; IVERMECTIN; PARAMYOSIN; PRASTERONE SULFATE; PRAZIQUANTEL; RECOMBINANT ANTIGEN; SCHISTOSOMA JAPONICUM VACCINE; SCHISTOSOMA VACCINE; SJ 23; SJ 26; UNCLASSIFIED DRUG; ANTHELMINTIC AGENT;

BOOK; CHEMOPROPHYLAXIS; CHEMOTHERAPY; CHINA; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DEMOGRAPHY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DRUG COST; ENDEMIC DISEASE; FECES ANALYSIS; GENOME ANALYSIS; GEOGRAPHIC INFORMATION SYSTEM; HEALTH EDUCATION; HUMAN; INFECTION CONTROL; INFECTION RESISTANCE; LYMPHATIC FILARIASIS; MEDICAL RESEARCH; MORBIDITY; NONHUMAN; ONCHOCERCIASIS; PARASITE SERODIAGNOSIS; PATHOGENESIS; PATIENT COMPLIANCE; PHILIPPINES; POPULATION GROWTH; PREVALENCE; PRIORITY JOURNAL; REMOTE SENSING; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS JAPONICA; SCHISTOSOMIASIS MANSONI; SOUTHEAST ASIA; ANIMAL; COMPARATIVE STUDY; INCIDENCE; ISOLATION AND PURIFICATION; MEDICATION COMPLIANCE;

ANIMALS; ANTHELMINTICS; CHINA; HUMANS; INCIDENCE; MEDICATION ADHERENCE; PHILIPPINES; PRAZIQUANTEL; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS;

EID: 77954586413     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-308X(10)72005-4     Document Type: Chapter

References (141)

1. Acosta L.P., Aligui G.D., Tiu W.U., McManus D.P., Olveda R.M. Immune correlate study on human Schistosoma japonicum in a well-defined population in Leyte, Philippines: I. Assessment of 'resistance' versus susceptibility to Schistosoma japonicum recombinant and native antigens. Acta Trop. 2002, 84:127-136.
2. Acosta L.P., Waine G., Aligui G.D., Tiu W.U., Olveda R.M., McManus D.P. Immune correlate study on human Schistosoma japonicum in a well-defined population in Leyte Philippines: II. Cellular immune responses to S. japonicum recombinant and native antigens. Acta Trop. 2002, 84:137-149.
3. Andrews P., Dycka J., Frank G. Effect of praziquantel on clinical-chemical parameters in healthy and schistosome-infected mice. Ann. Trop. Med. Parasitol. 1980, 74:167-177.
4. Andrews P., Thomas H., Pohlke R., Seubert J. Praziquantel. Med. Res. Rev. 1983, 3:147-200.
5. Balen J., Zhao Z.Y., Williams G.M., McManus D.P., Raso G., Utzinger J., et al. Prevalence, intensity and associated morbidity of Schistosoma japonicum infection in the Dongting Lake region, China. Bull. World Health Organ. 2007, 85:519-526.
6. Bergquist R., Al-Sherbiny M., Barakat R., Olds R. Blueprint for schistosomiasis vaccine development. Acta Trop. 2002, 82:183-192.
7. Bergquist R., Johansen M.V., Utzinger J. Diagnostic dilemmas in helminthology: what tools to use and when?. Trends Parasitol. 2009, 25:151-156.
8. Boelee E., Laamrani H. Environmental control of schistosomiasis through community participation in a Moroccan oasis. Trop. Med. Int. Health 2004, 9:997-1004.
9. Bustinduy A.L., King C.H. Parasitic helminths. Post-infectious sequelae and long-term consequences of infectious diseases 2009, 291-329. American Society for Microbiology Press, Washington.
10. Chen M.G. Schistosomiasis control program in the People's Republic of China: a review. Southeast Asian J. Trop. Med. Public Health 1989, 20:511-517.
11. Chen M.G. Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30years' experience. Acta Trop. 2005, 96:168-176.
12. Chen M.G., Feng Z. Schistosomiasis control in China. Parasitol. Int. 1999, 48:11-19.
13. Chen X.Y., Wu X.H., Wang L.Y., Dang H., Wang Q., Zheng J., et al. Schistosomiasis situation in the People's Republic of China in 2002. Chin. J. Schisto. Control 2003, 15:241-243.
14. Chen X.Y., Wang L.Y., Cai J.M., Zhou X.N., Zheng J., Guo J.G., et al. Schistosomiasis control in China: the impact of a 10-year World Bank loan project (1992-2001). Bull. World Health Organ. 2005, 83:43-48.
15. Coutinho H.M., Leenstra T., Acosta L.P., Su L., Jarilla B., Jiz M.A., et al. Pro-inflammatory cytokines and C-reactive protein are associated with undernutrition in the context of Schistosoma japonicum infection. Am. J. Trop. Med. Hyg. 2006, 75:720-726.
16. Da'dara A.A., Li Y.S., Xiong T., Zhou J., Williams G.M., McManus D.P., Feng Z., Yu X.L., Gray D.J., Harn D.A. DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine 2008, 26:3617-3625.
17. Dai Y., Zhu Y., Harn D.A., Wang X., Tang J., Zhao S., Lu F., Guan X. DNA vaccination by electroporation and boosting with recombinant proteins enhances the efficacy of DNA vaccines for Schistosomiasis japonica. Clin. Vaccine Immunol. 2009, 16:1796-1803.
18. Davis A., Wegner D.H. Multicentre trials of praziquantel in human schistosomiasis: design and techniques. Bull. World Health Organ. 1979, 57:767-771.
19. de Clercq D., Vercruysse J., Verlé P., Niasse F., Kongs A., Diop M. Efficacy of artesunate against Schistosoma mansoni infections in Richard Toll, Senegal. Trans. R. Soc. Trop. Med. Hyg. 2000, 94:90-91.
20. de Clercq D., Vercruysse J., Kongs A., Verlé P., Dompnier J.P., Faye P.C. Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren. Acta Trop. 2002, 82:61-66.
21. DeMarco R., Verjovski-Almeida S. Schistosomes-proteomics studies for potential novel vaccines and drug targets. Drug Discov. Today 2009, 14:472-478.
22. Doenhoff M.J., Cioli D., Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr. Opin. Infect. Dis. 2008, 21:659-667.
23. El Khoby T., Galal N., Fenwick A. The USAID/Government of Egypt's Schistosomiasis Research Project (SRP). Parasitol. Today 1998, 14:92-96.
24. Ellis M.K., McManus D.P. Familial aggregation of human helminth infection in the Poyang lake area of China with a focus on genetic susceptibility to schistosomiasis japonica and associated markers of disease. Parasitology. 2009, 136:699-712.
25. Fenwick A. New initiatives against Africa's worms. Trans. R. Soc. Trop. Med. Hyg. 2006, 100:200-207.
26. Fenwick A., Savioli L., Engels D., Bergquist N.R., Todd M.H. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol. 2003, 19:509-515.
27. Fenwick A., Webster J.P., Bosque-Oliva E., Blair L., Fleming F.M., Zhang Y., et al. The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. Parasitology 2009, 136:1719-1730.
28. Gao Z.Q., Jiang X.J., Cai Z.R., Wang L.X., Zheng Z.G., Huang D.S. Surveillance report on schistosomiasis ten years after reaching the criteria for elimination in Shanghai Municipality. Chin. J. Schisto. Control 1998, 10:159-161.
29. Garcia E.G. Clinical studies on schistosomiasis japonica in the Philippines: a review. Southeast Asian J. Trop. Med. Public Health 1976, 7:247-256.
30. Giboda M., Bergquist N.R. Post-transmission schistosomiasis: a new agenda. Acta Trop. 2000, 77:3-7.
31. Gönnert R., Andrews P. Praziquantel, a new board-spectrum antischistosomal agent. Z. Parasitenkd. 1977, 52:129-150.
32. Guo J.G., Cao C.L., Hu G.H., Lin H., Li D., Zhu R., et al. The role of 'passive chemotherapy' plus health education for schistosomiasis control in China during maintenance and consolidation phase. Acta Trop. 2005, 96:177-183.
33. Guo J.G., Vounatsou P., Cao C.L., Utzinger J., Zhu H.Q., Anderegg D., et al. A geographic information and remote sensing based model for prediction of Oncomelania hupensis habitats in the Poyang Lake area, China. Acta Trop. 2005, 96:213-222.
34. Hotez P.J., Molyneux D.H., Fenwick A., Kumaresan J., Ehrlich Sachs S., Sachs J.D., et al. Control of neglected tropical diseases. N. Engl. J. Med. 2007, 357:1018-1027.
35. Hu G.H., Hu J., Song K.Y., Lin D.D., Zhang J., Cao C.L., et al. The role of health education and health promotion in the control of schistosomiasis: experiences from a 12-year intervention study in Poyang Lake area. Acta Trop. 2005, 96:232-241.
36. Huang Y.X., Manderson L. The social and economic determinants of schistosomiasis japonica. Acta Trop. 2005, 96:223-231.
37. Huang S.Q., Zhang M.L. The medical and health service system in building socialist new countryside. Chin. Health Serv. Manage. 2007, 230:535-536.
38. Jiang Q.W., Zhang S.J., Yuan H.C., Liu Z., Zhao G.M., Brinkmann U. The effect of a combined approach to schistosomiasis control on the transmission of Schistosoma japonicum in Xingzi of Poyang Lake area, China. Southeast Asian J. Trop. Med. Public Health 1996, 27:535-541.
39. Jiraungkoorskul W., Sahaphong S., Sobhon P., Riengrojpitak S., Kangwanrangsan N. Effects of praziquantel and artesunate on the tegument of adult Schistosoma mekongi harboured in mice. Parasitol. Int. 2005, 54:177-183.
40. Johansen M.V., Sithithaworn P., Bergquist R., Utzinger J. Towards improved diagnosis of zoonotic trematodes in Asia. Adv. Parasitol. 2010, 73:171-195.
41. Katz N. Control in Brazil. Mem. Inst. Oswaldo Cruz 1998, 93(Suppl. 1):33-35.
42. Katz N., Chaves A., Pellegrino J. A simple device for quantitative stool thick smear technique in schistosomiasis mansoni. Rev. Inst. Med.Trop. São Paulo 1972, 14:397-400.
43. King C.H. Parasites and poverty: the case of schistosomiasis. Acta Trop. 2010, 113:95-104.
44. King C.H., Dickman K., Tisch D.J. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005, 365:1561-1569.
45. Kurtis J.D., Friedman J.F., Leenstra T., Langdon G.C., Wu H.W., Manalo D.L., et al. Pubertal development predicts resistance to infection and reinfection with Schistosoma japonicum. Clin. Infect. Dis. 2006, 42:1692-1698.
46. Lammie P.J., Fenwick A., Utzinger J. A blueprint for success: integration of neglected tropical disease control programmes. Trends Parasitol. 2006, 22:313-321.
47. Lengeler C., Utzinger J., Tanner M. Questionnaires for rapid screening of schistosomiasis in sub-Saharan Africa and their contribution to control. Bull. World Health Organ. 2002, 80:235-242.
48. Lengeler C., Utzinger J., Tanner M. Screening for schistosomiasis in sub-Saharan Africa. Trends Parasitol. 2002, 18:375-377.
49. Leonardo L.R., Rivera P., Saniel O., Villacorte E., Crisostomo B., Hernandez L., et al. Prevalence survey of schistosomiasis in Mindanao and the Visayas, the Philippines. Parasitol. Int. 2008, 57:246-251.
50. Li Y.S., Zhao Z.Y., Ellis M., McManus D.P. Applications and outcomes of periodic epidemiological surveys for schistosomiasis and related economic evaluation in the People's Republic of China. Acta Trop. 2005, 96:266-275.
51. Li S.Z., Luz A., Wang X.H., Xu L.L., Wang Q., Qian Y.J., et al. Schistosomiasis in China: acute infections during 2005-2008. Chin. Med. J. (Engl). 2009, 122:1009-1014.
52. Liese B. The organization of schistosomiasis control programmes. Parasitol. Today. 1986, 2:339-345.
53. Lin D.D., Liu J.X., Liu Y.M., Hu F., Zhang Y.Y., Xu J.M., et al. Routine Kato-Katz technique underestimates the prevalence of Schistosoma japonicum: a case study in an endemic area of the People's Republic of China. Parasitol. Int. 2008, 57:281-286.
54. Liu X.Y., Li D.J., Lin P.C., Lin J.X. Analysis on schistosomiasis surveillance for four years in Fujian province. Chin. J. Schisto. Control 1991, 3:229-230.
55. Maegraith B. Schistosomiasis in China. Lancet 1958, 271:208-214.
56. Malone J.B. Biology-based mapping of vector-borne parasites by geographic information systems and remote sensing. Parassitologia 2005, 47:27-50.
57. Mao S.P., Shao B.R. Schistosomiasis control in the People's Republic of China. Am. J. Trop. Med. Hyg. 1982, 31:92-99.
58. McGarvey S.T., Aligui G., Daniel B.L., Peters P., Olveda R., Olds G.R. Child growth and schistosomiasis japonica in northeastern Leyte, the Philippines: cross-sectional results. Am. J. Trop. Med. Hyg. 1992, 46:571-581.
59. McManus D.P., Dalton J.P. Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica. Parasitology 2006, 133(Suppl.):S43-61.
60. McManus D.P., Loukas A. The current status of vaccines for schistosomiasis. Clin. Microbiol. Rev. 2008, 21:225-242.
61. McMullen D.B., Hubendick B., Pesigan T.P., Bierstein P. Observations made by the World Health Organization schistosomiasis team in the Philippines. J. Philipp. Med. Assoc. 1954, 30:615-627.
62. Ministry of Health Epidemic Status of Schistosomiasis in China: A Nation Wide Sampling Survey in 1995 1998, Nanjing University Press, Nanjing, China.
63. Mitchell G.F., Garcia E.G., Rivera P.T., Tiu W.U., Davern K.M. Evidence for and implications of anti-embryonation immunity in schistosomiasis. Exp. Parasitol. 1994, 79:546-549.
64. Mott K.E., Dixon H. Collaborative study on antigens for immunodiagnosis of schistosomiasis. Bull. World Health Organ. 1982, 60:729-753.
65. Mott K.E., Dixon H., Carter C.E., Garcia E., Ishii A., Matsuda H., et al. Collaborative study on antigens for immunodiagnosis of Schistosoma japonicum infection. Bull. World Health Organ. 1987, 65:233-244.
66. Murray C.J.L., Lopez A.D. The Global Burden of Disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 1996, Harvard School of Public Health/World Bank, Cambridge, MA, USA.
67. Muth S., Sayasone S., Odermatt-Biays S., Phompida S., Duong S., Odermatt P., et al. Schistosoma mekongi in Cambodia and Lao People's Democratic Republic. Adv. Parasitol. 2010, 72:179-203.
68. N'Goran E.K., Utzinger J., Gnaka H.N., Yapi A., N'Guessan N.A., Kigbafori S.D., et al. Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections. Am. J. Trop. Med. Hyg. 2003, 68:24-32.
69. Olveda R.M., Tiu E., Fevidal P., De Veyra F., Icatlo F., Domingo E.O. The relationship of prevalence and intensity of infection with morbidity in schistosomiasis japonica: a study of three communities in Leyte, Philippines. Am. J. Trop. Med. Hyg. 1983, 32:1312-1321.
70. Olveda R.M., Daniel B.L., Ramirez B.D., Aligui G.L., Acosta L.P., Fevidal P., et al. Schistosomiasis japonica in the Philippines: the long-term impact of population-based chemotherapy on infection, transmission and morbidity. J. Infect. Dis. 1996, 174:163-172.
71. Pesigan T.P., Farooq M., Hairston N.G., Jauregui J.J., Garcia E.G., Santos A.T., et al. Studies on Schistosoma japonicum infection in the Philippines. 1. General considerations and epidemiology. Bull. World Health Organ. 1958, 18:345-455.
72. Ramirez B.L., Kurtis J.D., Wiest P.M., Arias P., Aligui F., Acosta L., et al. Paramyosin: a candidate vaccine antigen against Schistosoma japonicum. Parasite Immunol. 1996, 18:49-52.
73. Reimert C.M., Tukahebwa E.M., Kabatereine N.B., Dunne D.W., Vennervald B.J. Assessment of Schistosoma mansoni induced intestinal inflammation by means of eosinophil cationic protein eosinophil protein X and myeloperoxidase before and after treatment with praziquantel. Acta Trop. 2008, 105:253-259.
74. Ridley R.G. Product R&D for neglected diseases. Twenty-seven years of WHO/TDR experiences with public-private partnerships. EMBO Rep. 2003, 4:S43-S46.
75. Santiago M.L.O., Hafalla J.C.R., Kurtis J.D., Aligui G.L., Wiest P.M., Olveda R.M., et al. Identification of Schistosoma japonicum 22.6-kDa: a major target of human IgE response: similarity of IgE binding epitopes to allergen peptides. Int. Arch. Allergy Immunol. 1998, 117:94-104.
76. Santos A.T. The schistosomiasis control program in the Philippines. World Med. J. 1967, 14:23-24.
77. Santos A.T. The present status of schistosomiasis in the Philippines. Southeast Asian J. Trop. Med. Public Health 1984, 15:439-445.
78. Zhou Y., Zheng H., Liu F., Hu W., Wang Z.Q., Gang L., Ren S. The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 2009, 460:345-351. Schistosoma japonicum Genome Sequencing and Functional Analysis Consortium.
79. Seto E.Y.W., Knapp F., Zhong B., Yang C. The use of a vest equipped with a global positioning system to assess water-contact patterns associated with schistosomiasis. Geospat. Health 2007, 2:233-241.
80. Shi M.Z., Yu D.B., Wei W.Y., Zhang C.S., He H.B., Yang G.F., et al. Experimental study on susceptibility of praziquantel against Schistosoma japonicum in repeated chemotherapy areas in Dongting Lake region. Chin. J. Schisto. Control 2004, 16:171-173.
81. Smith D.B., Davern K.M., Board P.G., Tiu W.U., Garcia E.G., Mitchell G.F. Mr 26,000 antigen of Schistosoma japonicum recognized by resistant WEHI 129/J mice is a parasite glutathione S-transferase. Proc. Natl Acad. Sci. USA 1986, 83:8703-8707.
82. Song H.T., Liang Y.S., Dai J.R., Li L.G., Shen X.H., Tian Q.A., et al. Studies on sensitivity of Schistosoma japonicum to praziquantel - situation in low endemic areas. Chin. J. Schisto. Control 2004, 16:58-59.
83. Spear R.C., Seto E., Liang S., Birkner M., Hubbard A., Qiu D., et al. Factors influencing the transmission of Schistosoma japonicum in the mountains of Sichuan province of China. Am. J. Trop. Med. Hyg. 2004, 70:48-56.
84. Steinmann P., Keiser J., Bos R., Tanner M., Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect. Dis. 2006, 6:411-425.
85. Steinmann P., Zhou X.N., Li Y.L., Li H.J., Chen S.R., Yang Z., et al. Helminth infections and risk factor analysis among residents in Eryuan county, Yunnan province, China. Acta Trop. 2007, 104:38-51.
86. Steinmann P., Zhou X.N., Matthys B., Li Y.L., Li H.J., Chen S.R., et al. Spatial risk profiling of Schistosoma japonicum in Eryuan county, Yunnan province, China. Geospat. Health 2007, 2:59-73.
87. Stothard J.R., Gabrielli A.F. Schistosomiasis in African infants and preschool children: to treat or not to treat?. Trends Parasitol. 2007, 23:83-86.
88. Tan H.Z., Yang M.X., Wu Z.G., Zhou J., Liu A.Z., Li S.Q., et al. Rapid screening method for Schistosoma japonicum infection using questionnaires in flood area of the People's Republic of China. Acta Trop. 2004, 90:1-9.
89. Tang D.L., Yu D.B., Li Y.Y., Xie M.S., Wen H.M., Cai W.B., et al. Analysis of cost-effectiveness on two chemotherapy schemes to schistosomiasis in hyperendemic villages of Hunan province. Prac. Prev. Med. 2001, 8:165-168.
90. Tao H.Q., Li S.W. Consolidation and surveillance situation and suggestion for schistosomiasis control in Zhejiang province. Chin. J. Schisto. Control 1999, 11:226-227.
91. Tubangui M.A. The molluscan intermediate host in the Philippines of the oriental blood fluke Schistosoma japonicum Kutsurada. Philipp. J. Sci. 1932, 49:295-304.
92. Utzinger J., N'Goran E.K., N'Dri A., Lengeler C., Xiao S.H., Tanner M. Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet 2000, 355:1320-1325.
93. Utzinger J., Booth M., N'Goran E.K., Müller I., Tanner M., Lengeler C. Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel. Parasitology 2001, 122:537-544.
94. Utzinger J., Xiao S.H., N'Goran E.K., Bergquist R., Tanner M. The potential of artemether for the control of schistosomiasis. Int. J. Parasitol. 2001, 31:1549-1562.
95. Utzinger J., Keiser J., Xiao S.H., Tanner M., Singer B.H. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob. Agents Chemother. 2003, 47:1487-1495.
96. Utzinger J., Zhou X.N., Chen M.G., Bergquist R. Conquering schistosomiasis in China: the long march. Acta Trop. 2005, 96:69-96.
97. Utzinger J., Xiao S.H., Tanner M., Keiser J. Artemisinins for schistosomiasis and beyond. Curr. Opin. Investig. Drugs 2007, 8:105-116.
98. Utzinger J., Raso G., Brooker S., de Savigny D., Tanner M., Ørnbjerg N., et al. Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology 2009, 136:1859-1874.
99. Verjovski-Almeida S., Leite L.C.C., Dias-Neto E., Menck C.F.M., Wilson R.A. Schistosome transcriptome: insights and perspectives for functional genomics. Trends Parasitol. 2004, 20:304-308.
100. Wang X.Z., Li S.T., Zhou Z.X. A rapid one-step method of EIA for detection of circulating antigen of Schistosoma japonicum. Chin. Med. J. 1999, 112:124-128.
101. Wang L.D., Chen H.G., Guo J.G., Zeng X.J., Hong X.L., Xiong J.J., et al. A strategy to control transmission of Schistosoma japonicum in China. N. Engl. J. Med. 2009, 360:121-128.
102. Wang L.D., Guo J.G., Wu X.H., Chen H.G., Wang T.P., Zhu S.P., et al. China's new strategy to block Schistosoma japonicum transmission: experiences and impact beyond schistosomiasis. Trop. Med. Int. Health 2009, 14:1475-1483.
103. Wen L.Y., Chen J.H., Ding J.Z., Zhang J.F., Lu S.H., Yu L.L., et al. Evaluation on the applied value of the dot immunogold filtration assay (DIGFA) for rapid detection of anti-Schistosoma japonicum antibody. Acta Trop. 2005, 96:142-147.
104. WHO The control of schistosomiasis. Report of a WHO expert committee. WHO Tech. Rep. Ser. 1985, 728:1-113.
105. WHO The control of schistosomiasis. Second report of the WHO expert committee. WHO Tech. Rep. Ser. 1993, 830:1-86.
106. WHO Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. WHO Tech. Rep. Ser. 2002, 912:1-57.
107. WHO The World Health Report 2004 - Changing History 2004, World Health Organization, Geneva.
108. Preventive chemotherapy (PCT) databank WHO, (Accessed: 15 December 2009). http://www.who.int/neglected_diseases/preventive_chemotherapy/databank/en/index.html.
109. Williams G.M., Sleigh A.C., Li Y.S., Feng Z., Davis G.M., Chen H., et al. Mathematical modelling of schistosomiasis japonica: comparison of control strategies in the People's Republic of China. Acta Trop. 2002, 82:253-262.
110. Wu X.H., Chen M.G., Zheng J. Surveillance of schistosomiasis in five provinces of China which have reached the national criteria for elimination of the disease. Acta Trop. 2005, 96:276-281.
111. Wu X.H., Wang X.H., Utzinger J., Yang K., Kristensen T.K., Bergquist R., et al. Spatio-temporal correlation between human and bovine schistosomiasis in China: insight from three national sampling surveys. Geospat. Health 2007, 2:75-84.
112. Xiao S.H. Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins. Acta Trop. 2005, 96:153-167.
113. Xiao S.H., Yue W.J., Yang Y.Q., You J.Q. Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel. Chin. Med. J. 1987, 100:759-768.
114. Xiao S.H., Booth M., Tanner M. The prophylactic effects of artemether against Schistosoma japonicum infections. Parasitol. Today 2000, 16:122-126.
115. Xiao S.H., Tanner M., N'Goran E.K., Utzinger J., Chollet J., Bergquist R., et al. Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop. 2002, 82:175-181.
116. Xiao X., Wang T.P., Tian Z.G. Development of a rapid, sensitive, dye immunoassay for schistosomiasis diagnosis: a colloidal dye immunofiltration assay. J. Immunol. Methods 2003, 280:49-57.
117. Xiao X., Wang T.P., Ye H.Z., Qiang G.X., Wei H.M., Tian Z.G. Field evaluation of a rapid, visually-read colloidal dye immunofiltration assay for Schistosoma japonicum for screening in areas of low transmission. Bull. World Health Organ. 2005, 83:526-533.
118. Xiao S.H., Keiser J., Chollet J., Utzinger J., Dong Y., Endriss Y., et al. In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species. Antimicrob. Agents Chemother. 2007, 51:1440-1445.
119. Xiao S.H., Keiser J., Chen M.G., Tanner M., Utzinger J. Research and development of antischistosomal drugs in the People's Republic of China: a 60-year review. Adv. Parasitol. 2010, 73:231-295.
120. Xu X.J., Wei F.H., Yang X.X., Dai Y.H., Yu G.Y., Chen L.Y., et al. Possible effects of the Three Gorges dam on the transmission of Schistosoma japonicum on the Jiang Han plain China. Ann. Trop. Med. Parasitol. 2000, 94:333-341.
121. Yang G.J., Vounatsou P., Zhou X.N., Utzinger J., Tanner M. A review of geographic information system and remote sensing with applications to the epidemiology and control of schistosomiasis in China. Acta Trop. 2005, 96:117-129.
122. Yang G.J., Vounatsou P., Tanner M., Zhou X.N., Utzinger J. Remote sensing for predicting potential habitats of Oncomelania hupensis in Hongze, Baima and Gaoyou lakes in Jiangsu province, China. Geospat. Health 2006, 1:85-92.
123. Yuan H., Jiagang G., Bergquist R., Tanner M., Xianyi C., Huanzeng W. The 1992-1999 World Bank Schistosomiasis Research Initiative in China: outcome and perspectives. Parasitol. Int. 2000, 49:195-207.
124. Yuan L.P., Manderson L., Tempongko M.S.B., Wei W.Y., Aiguo P. The impact of educational videotapes on water contact behaviour of primary school students in the Dongting Lakes region, China. Trop. Med. Int. Health 2000, 5:538-544.
125. Zhang Z.Y., Xue D.Z., Zhou X.N., Zhou Y., Liu S.J. Remote sensing and spatial statistical analysis to predict the distribution of Oncomelania hupensis in the marshlands of China. Acta Trop. 2005, 96:205-212.
126. Zhao W.X., Wu G.L., Guan X.H. Immunodiagnosis of Schistosoma japonicum infection in China. Chin. Med. J. 1993, 106:623-627.
127. Zhao G.M., Zhao Q., Jiang Q.W., Chen X.Y., Wang L.Y., Yuan H.C. Surveillance for schistosomiasis japonica in China from 2000 to 2003. Acta Trop. 2005, 96:288-295.
128. Zhen J. A brief introduction to a nation-wide sampling survey on schistosomiasis. Chin. Med. J. 1993, 106:569-575.
129. Zhou H., Ross A.G.P., Hartel G.F., Sleigh A.C., Williams G.M., McManus D.P., et al. Diagnosis of schistosomiasis japonica in Chinese schoolchildren by administration of a questionnaire. Trans. R. Soc. Trop. Med. Hyg. 1998, 92:245-250.
130. Zhou X.N., Malone J.B., Kristensen T.K., Bergquist N.R. Application of geographic information systems and remote sensing to schistosomiasis control in China. Acta Trop. 2001, 79:97-106.
131. Zhou X.N., Acosta L., Willingham A.L., Leonardo L.R., Chen M.G., Aligui G., et al. Regional Network for Research, Surveillance and Control of Asian Schistosomiasis (RNAS). Acta Trop. 2002, 82:305-311.
132. Zhou X.N., Wang L.Y., Chen M.G., Wang T.P., Guo J.G., Wu X.H., et al. An economic evaluation of the national schistosomiasis control programme in China from 1992 to 2000. Acta Trop. 2005, 96:255-265.
133. Zhou X.N., Wang L.Y., Chen M.G., Wu X.H., Jiang Q.W., Chen X.Y., et al. The public health significance and control of schistosomiasis in China - then and now. Acta Trop. 2005, 96:97-105.
134. Zhou X.N., Guo J.G., Wu X.H., Jiang Q.W., Zheng J., Dang H., et al. Epidemiology of schistosomiasis in the People's Republic of China, 2004. Emerg. Infect. Dis. 2007, 13:1470-1476.
135. + : a win-win collaboration to combat neglected tropical diseases in Southeast Asia. Parasitol. Int. 2008, 57:243-245.
136. Zhou X.N., Yang G.J., Yang K., Wang X.H., Hong Q.B., Sun L.P., et al. Potential impact of climate change on schistosomiasis transmission in China. Am. J. Trop. Med. Hyg. 2008, 78:188-194.
137. Zhou X.N., Bergquist R., Leonardo L., Yang G.J., Yang K., Sudomo M., et al. Schistosomiasis japonica: research and control. Adv. Parasitol. 2010, 72:145-178.
138. Zhu Y.C. Immunodiagnosis and its role in schistosomiasis control in China: a review. Acta Trop. 2005, 96:130-136.
139. Zhu Y.C., He W., Liang Y.S., Xu M., Yu C.X., Hua W.Q., et al. Development of a rapid, simple dipstick dye immunoassay for schistosomiasis diagnosis. J. Immunol. Methods 2002, 266:1-5.
140. Zhu Y., Ren J., Da'dara A., Harn D., Xu M., Si J., et al. The protective effect of a Schistosoma japonicum Chinese strain 23 kDa plasmid DNA vaccine in pigs is enhanced with IL-12. Vaccine 2004, 23:78-83.
141. Zhu Y., Si J., Harn D.A., Xu M., Ren J., Yu C., et al. Schistosoma japonicum triose-phosphate isomerase plasmid DNA vaccine protects pigs against challenge infection. Parasitology 2006, 132:67-71.